Implications of the International Society of Urological Pathology Modified Gleason Grading System

被引:46
作者
Egevad, Lars [2 ]
Mazzucchelli, Roberta [1 ]
Montironi, Rodolfo [1 ]
机构
[1] Polytech Univ Marche Reg, Sch Med, United Hosp, Sect Pathol Anat, I-60126 Ancona, Italy
[2] Karolinska Univ Hosp, Dept Pathol, Stockholm, Sweden
关键词
PROSTATE NEEDLE-BIOPSY; CONSENSUS CONFERENCE; ISUP CONSENSUS; CARCINOMA; INTEROBSERVER; PROGNOSIS; CANCER; SCORE; REPRODUCIBILITY; SPECIMENS;
D O I
10.5858/arpa.2011-0495-RA
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Context.-Histologic grading is the clinically most useful tissue-based predictor of prognosis for prostate cancer. Over the years, there has been a gradual shift in how the Gleason grading is applied in practice, with a general trend toward upgrading. A consensus conference was organized in 2005 by the International Society of Urological Pathology (ISUP) for standardizing both the perception of histologic patterns and how the grade information is compiled and reported. Objective.-To review the implications of the ISUP modified Gleason grading system. Data Sources.-Personal experience and review of the current literature. Conclusions.-The recommendations regarding pattern interpretation and reporting are summarized. The practical consequences of the ISUP modification of the Gleason grading are reported. The prognostic importance of the Gleason score, its reproducibility, and its preoperative assessment are discussed. Subsequent proposals for slight modifications to the ISUP grading system are described. (Arch Pathol Lab Med. 2012; 136:426-434; doi: 10.5858/arpa.2011-0495-RA)
引用
收藏
页码:426 / 434
页数:9
相关论文
共 41 条
[1]
Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens [J].
Amin, M ;
Boccon-Gibod, L ;
Egevad, L ;
Epstein, JI ;
Humphrey, PA ;
Mikuz, G ;
Newling, D ;
Nilsson, S ;
Sakr, W ;
Srigley, JR ;
Wheeler, TM ;
Montironi, R .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2005, 39 :20-33
[2]
AMIN MB, 1994, ARCH PATHOL LAB MED, V118, P260
[3]
Low Gleason score prostatic adenocarcinomas are no longer viable entities [J].
Berney, D. M. .
HISTOPATHOLOGY, 2007, 50 (06) :683-690
[4]
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading [J].
Berney, Daniel M. ;
Fisher, Gabrielle ;
Kattan, Michael W. ;
Oliver, R. Timothy D. ;
Moller, Henrik ;
Fearn, Paul ;
Eastham, James ;
Scardino, Peter ;
Cuzick, Jack ;
Reuter, Victor E. ;
Foster, Christopher S. .
BJU INTERNATIONAL, 2007, 100 (06) :1240-1244
[5]
The case for modifying the gleason grading system [J].
Berney, Daniel M. .
BJU INTERNATIONAL, 2007, 100 (04) :725-726
[6]
The impact of the 2005 International Society of Urological Pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies [J].
Billis, Athanase ;
Guimaraes, Marbele S. ;
Freitas, Leandro L. L. ;
Meirelles, Luciana ;
Magna, Luis A. ;
Ferreira, Ubirajara .
JOURNAL OF UROLOGY, 2008, 180 (02) :548-552
[7]
Bostwick DG, 2000, PROSTATE CANCER, P161
[8]
Gleason scoring: a comparison of classical and modified (International Society of Urological Pathology) criteria using nadir PSA as a clinical end point [J].
Delahunt, Brett ;
Lamb, David S. ;
Srigley, John R. ;
Murray, Judy D. ;
Wilcox, Chantelle ;
Samaratunga, Hemamali ;
Atkinson, Christopher ;
Spry, Nigel A. ;
Joseph, David ;
Denham, James W. .
PATHOLOGY, 2010, 42 (04) :339-343
[9]
Current practice of Gleason grading among genitourinary pathologists [J].
Egevad, L ;
Allsbrook, WC ;
Epstein, JI .
HUMAN PATHOLOGY, 2005, 36 (01) :5-9
[10]
Egevad L:., 1999, J Urol Pathol, P23